Symrise taps biotch firm Cutech


New deal will accelerate the development of active ingredients based on predictive ex vivo models

You need to be a subscriber to read this article.
Click here to find out more.

German ingredients supplier Symrise has announced the acquisition of Italian biotech company Cutech.

Details of the purchase were not disclosed.

The new agreement will provide Symrise with expertise in pre-clinical screening services for cosmetic ingredients and finished formulations and will expand Symrise’s presence in the efficacy testing of cosmetic ingredients, as well as bringing new opportunities for collaboration with partners from scientific institutions and increasing the go-to-market speed for novel active ingredients.

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.

Subscribe now Already a subscriber? Sign in here.

Relevant companies

You may also like